Bristol Heart Institute, University of Bristol, Bristol, UK.
Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
Eur J Cardiothorac Surg. 2021 Dec 1;60(6):1437-1444. doi: 10.1093/ejcts/ezab192.
The risk of brain injury following surgery for type A aortic dissection (TAAD) remains substantial and no consensus has still been reached on which neuroprotective technique should be preferred. We aimed to investigate the association between neuroprotective strategies and clinical outcomes following TAAD repair.
Using the UK National Adult Cardiac Surgical Audit, we identified 1929 patients undergoing surgery for TAAD (2011-2018). Deep hypothermic circulatory arrest (DHCA) only, unilateral (uACP), bilateral antegrade cerebral perfusion (bACP) and retrograde cerebral perfusion were used in 830, 117, 760 and 222 patients, respectively. The primary end point was a composite of death and/or cerebrovascular accident (CVA). Generalized linear mixed model was used to adjust the effect of neuroprotective strategies for other confounders.
The use of bACP was associated with longer circulatory arrest (CA) compared to other strategies. There was a trend towards lower incidence of death and/or CVA using uACP only for shorter CA. In particular, primary end point rate was 27.7% overall and 26.5%, 12.5%, 28.0% and 22.9% for CA <30 min and 28.6%, 30.4%, 33.3% and 33.0% for CA ≥30 min with DHCA only, uACP, bACP and retrograde cerebral perfusion, respectively. The use of DHCA only was associated with five-fold [odds ratio (OR) 5.35, 95% confidence interval (CI) 1.36-21.02] and two-fold (OR 1.77, 95% CI 1.01-3.09) increased risk of death and/or CVA compared to uACP and bACP, respectively, but the effect of uACP was significantly associated with CA duration (hazard ratio 0.97, 95% CI 0.94-0.99; P = 0.04).
In TAAD repair, the use of uACP and bACP was associated with a lower adjusted risk of death and/or CVA when compared to DHCA. uACP can offer some advantage but only for a shorter CA duration.
A型主动脉夹层(TAAD)手术后发生脑损伤的风险仍然很大,对于应优先采用哪种神经保护技术,目前仍未达成共识。我们旨在研究 TAAD 修复后神经保护策略与临床结局之间的关系。
利用英国国家成人心脏手术审核,我们共纳入了 1929 名接受 TAAD 手术的患者(2011-2018 年)。830 例患者采用单纯深低温停循环(DHCA),117 例患者采用单侧脑动脉灌注(uACP),760 例患者采用双侧顺行脑灌注(bACP),222 例患者采用逆行脑灌注。主要终点是死亡和/或卒中等复合终点。使用广义线性混合模型来调整其他混杂因素对神经保护策略的影响。
bACP 的使用与其他策略相比,需要更长的体外循环时间(CA)。与其他策略相比,uACP 仅用于较短的 CA 时间,死亡和/或卒中等复合终点的发生率呈下降趋势。特别是,总的主要终点发生率为 27.7%,CA<30min 时分别为 26.5%、12.5%、28.0%和 22.9%,CA≥30min 时分别为 28.6%、30.4%、33.3%和 33.0%,分别为单纯 DHCA、uACP、bACP 和逆行脑灌注。单纯 DHCA 的使用与 uACP(比值比[OR]5.35,95%置信区间[CI]1.36-21.02)和 bACP(OR 1.77,95%CI 1.01-3.09)相比,死亡和/或卒中等复合终点的风险分别增加了五倍和两倍,但 uACP 的作用与 CA 持续时间显著相关(风险比 0.97,95%CI 0.94-0.99;P=0.04)。
在 TAAD 修复中,与 DHCA 相比,uACP 和 bACP 的使用与死亡和/或卒中等复合终点的风险降低相关。uACP 可能具有一定优势,但仅适用于较短的 CA 持续时间。